Login / Signup

Towards precision radiation oncology: endocrine therapy response as a biomarker for personalization of breast radiotherapy.

S M Nashir UddenGuemHee BaekKamal PandeyChantal VidalYulun LiuAsal S RahimiD Nathan KimChika R NwachukwuRam S ManiPrasanna G Alluri
Published in: NPJ precision oncology (2023)
Targeted therapies, such as endocrine therapies (ET), can exert selective pressure on cancer cells and promote adaptations that confer treatment resistance. In this study, we show that ET resistance in breast cancer drives radiation resistance through reprogramming of DNA repair pathways. We also show that pharmacological bromodomain and extraterminal domain inhibition reverses pathological DNA repair reprogramming in ET-resistant breast tumors and overcomes resistance to radiation therapy.
Keyphrases